2022 Annual Meeting Virtual Experience | PL5 - Frontiers in Neuroscience Plenary Session

Date Tuesday 04/26/22

Time 10:00 AM - 12:30 PM EDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Plenary Session

Director(s) Paul M. George, MD, PhD, MSE, FAAN

Topic(s) Aging, Dementia, and Behavioral Neurology, General Neurology, Infectious Disease, Multiple Sclerosis, Neuromuscular and Clinical Neurophysiology (EMG)

Learning Objectives This plenary session features basic and translational research related to clinical issues of importance. Hear from four outstanding speakers as they summarize their recent research finding and dive into the clinical implications of the results.

CME Available 2.50 CME credits

Program Materials Program Evaluations

Event Timeline
10:00 AM - 10:05 AM EDT	Introduction	Introduction Paul M. George, MD, PhD, MSE, FAAN
10:05 AM - 10:30 AM EDT	Speaker	Roles of Astrocytes in CNS Inflammation Francisco J. Quintana, PhD
10:30 AM - 10:35 AM EDT	Introduction	Introduction Paul M. George, MD, PhD, MSE, FAAN
10:35 AM - 11:00 AM EDT	Speaker	Mapping the ALS Exposome: A Step Towards Prevention Eva Feldman, MD, PhD, FAAN
11:00 AM - 11:05 AM EDT	Introduction	Introduction Paul M. George, MD, PhD, MSE, FAAN
11:05 AM - 11:30 AM EDT	Speaker	Tau Protein as a Therapeutic Target and Biomarker for Neurological Disease Adam L. Boxer, MD, PhD
11:30 AM - 11:35 AM EDT	Introduction	Introduction Paul M. George, MD, PhD, MSE, FAAN
11:35 AM - 12:00 PM EDT	Speaker	Neurobiology of COVID-19 Robyn S. Klein, MD, PhD
12:00 PM - 12:30 PM EDT	Q&A	Fireside Chat Francisco J. Quintana, PhD, Paul M. George, MD, PhD, MSE, FAAN, Robyn S. Klein, MD, PhD, Adam L. Boxer, MD, PhD, Eva Feldman, MD, PhD, FAAN

Faculty Disclosures
Paul M. George, MD, PhD, MSE, FAAN	Dr. George has received personal compensation in the range of $0-$499 for serving as a Consultant for ConductiveBio. Dr. George has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Law firms. The institution of Dr. George has received research support from Conductive Bio. The institution of Dr. George has received research support from NIH.
Francisco J. Quintana, PhD	Dr. Quintana has nothing to disclose.
Robyn S. Klein, MD, PhD	No disclosure on file
Adam L. Boxer, MD, PhD	An immediate family member of Dr. Boxer has received personal compensation for serving as an employee of Kaiser Permanente. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Third Rock. Dr. Boxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Transposon. Dr. Boxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Oligomerix. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Humana. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Wave. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer Ingelheim. Dr. Boxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Oscotec. Dr. Boxer has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arvinas. Dr. Boxer has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arkuda. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AZTherapeutics. Dr. Boxer has stock in Alector. Dr. Boxer has stock in Arkuda. Dr. Boxer has stock in Arvinas. An immediate family member of Dr. Boxer has stock in AZtherapies. Dr. Boxer has stock in TrueBinding. The institution of Dr. Boxer has received research support from Biogen. The institution of Dr. Boxer has received research support from Eisai. The institution of Dr. Boxer has received research support from Regeneron. The institution of Dr. Boxer has received research support from NIH. The institution of Dr. Boxer has received research support from Bluefield Project. Dr. Boxer has received research support from Rainwater Charitable Foundation. The institution of Dr. Boxer has received research support from Association for Frontotemporal Degeneration.
Eva Feldman, MD, PhD, FAAN	The institution of Dr. Feldman has received research support from National Institutes of Health. The institution of Dr. Feldman has received research support from Centers for Disease Control and Prevention / Agency for Toxic Substances and Disease Registry. The institution of Dr. Feldman has received research support from Juvenile Diabetes Research Foundation. Dr. Feldman has received intellectual property interests from a discovery or technology relating to health care. Dr. Feldman has a non-compensated relationship as a Editorial Board Member with Journal of the Peripheral Nervous System, Experimental Neurology, Nature Neurology Reviews, Neurobiology of Disease, NeuroRx, Journal of Neurology Neurosurgery and Psychiatry, Scientific Reports, Lancet Neurology, Med (Cell Press Journal) that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Editor-in-Chief with Oxford University Press Contemporary Neurology Series that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Membership Committee Member, Strategic Planning Committee Member, and Chair of Section 07 with National Academy of Medicine that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Associate Editor with Annals of Neurology that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Governance Committee Chair with American Neurological Association that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Membership Committee Member, Strategic Planning Committee Member, Chair of Section 07, Neuroscience Forum, Council Member with National Academy of Medicine that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Committee on Making ALS a Livable Disease Member with National Academy of Sciences, Engineering, and Medicine that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Member, Blueprint Neurotherapeutics Network for Biologics (BPN-Biologics) External Oversight Committee with National Institutes of Health that is relevant to AAN interests or activities.